Literature DB >> 3936658

Normalization of defective interleukin 1 and interleukin 2 production in patients with pemphigus vulgaris following chrysotherapy.

E Blitstein-Willinger.   

Abstract

The aim of this study was to investigate the origins of disturbances of immunoreactivity in patients with pemphigus vulgaris. Peripheral mononuclear blood cells of PV patients showed reduced proliferative responses to lectins in vitro. The capacity of these cells to produce IL-1 and IL-2 was tested. A severe defect in both IL-1 and IL-2 production was observed; in addition, the capacity of the cells to express IL-2 receptors in response to PHA was diminished. The defects did not result from concurrent corticosteroid therapy. The positive therapeutic effect of gold sodium thiomalate therapy correlated with the normalization in the cell's capacity to produce IL-1 and IL-2. It seems possible that the observed deficiencies are related to the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3936658      PMCID: PMC1577493     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  DEMONSTRATION OF SKIN ANTIBODIES IN SERA OF PEMPHIGUS VULGARIS PATIENTS BY INDIRECT IMMUNOFLUORESCENT STAINING.

Authors:  E H BEUTNER; R E JORDON
Journal:  Proc Soc Exp Biol Med       Date:  1964-11

2.  Glucocorticoid-induced inhibition of T cell growth factor production. II. The effect on the in vitro generation of cytolytic T cells.

Authors:  S Gillis; G R Crabtree; K A Smith
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

Review 3.  Pemphigus and pemphigoid. A review of the advances made since 1964.

Authors:  W F Lever
Journal:  J Am Acad Dermatol       Date:  1979-07       Impact factor: 11.527

4.  Polyanions and lipopolysaccharide acts on different subpopulations of B cells.

Authors:  T Diamantstein; E Blitstein-Willinger; G Schulz
Journal:  Nature       Date:  1974-08-16       Impact factor: 49.962

5.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

6.  Separation of functional subsets of human T cells by a monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

7.  Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation.

Authors:  S Gillis; G R Crabtree; K A Smith
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

Review 8.  T-cell growth factor.

Authors:  K A Smith
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

9.  Ligand-activated T cell growth factor-induced proliferation: absorption of T cell growth factor by activated T cells.

Authors:  G D Bonnard; K Yasaka; D Jacobson
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

10.  Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans.

Authors:  S Gillis; R Kozak; M Durante; M E Weksler
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

View more
  5 in total

1.  The effect of experimental haemocarbofiltration upon activity of mononuclear cells from normal and autoimmune patients.

Authors:  S A Grando; B T Glukhenky; G N Drannik; A P Kostromin; A B Romanenko
Journal:  Immunology       Date:  1989-01       Impact factor: 7.397

Review 2.  The present status of anti-inflammatory agents in dermatology.

Authors:  G Stüttgen
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Effect of gold salt treatment on the receptor binding activity of monocytes and macrophages isolated from rats with adjuvant arthritis.

Authors:  D R Haynes; I R Garrett; B Vernon-Roberts
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

4.  The stimulation of IL-2 production by anti-rheumatic drugs.

Authors:  J A Oben; G R Wallace; B M Chain; J C Foreman
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

5.  The interleukin-2 receptor in lesions and serum of bullous pemphigoid.

Authors:  D Zillikens; A Ambach; M Schuessler; R Dummer; A A Hartmann; G Burg
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.